These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 26840083

  • 1. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
    Zang C, Nie FQ, Wang Q, Sun M, Li W, He J, Zhang M, Lu KH.
    Oncotarget; 2016 Mar 08; 7(10):11696-707. PubMed ID: 26840083
    [Abstract] [Full Text] [Related]

  • 2. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W, Sun M, Zang C, Ma P, He J, Zhang M, Huang Z, Ding Y, Shu Y.
    Cell Death Dis; 2016 May 19; 7(5):e2225. PubMed ID: 27195672
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J, Sun CC, Gong C.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):811-7. PubMed ID: 27501756
    [Abstract] [Full Text] [Related]

  • 4. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY, Zhang SR, Wang LH, Wu WD, Zhao H.
    Eur Rev Med Pharmacol Sci; 2019 Oct 16; 23(19):8377-8390. PubMed ID: 31646568
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
    Liu JQ, Feng YH, Zeng S, Zhong MZ.
    Life Sci; 2020 Jan 15; 241():117134. PubMed ID: 31811854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.
    Lian Y, Wang J, Feng J, Ding J, Ma Z, Li J, Peng P, De W, Wang K.
    Tumour Biol; 2016 Nov 15; 37(11):14929-14937. PubMed ID: 27644252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
    Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, Liu YW, Liu XH, Zhang EB, Lu KH, Shu YQ.
    Mol Cancer Ther; 2015 Jan 15; 14(1):268-77. PubMed ID: 25504755
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression.
    Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B, Zhang T, Zhou Y, Chen Q, Wei C, Wang W, Wang Z.
    Cell Death Dis; 2017 Oct 05; 8(10):e3092. PubMed ID: 28981099
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
    Nie F, Yu X, Huang M, Wang Y, Xie M, Ma H, Wang Z, De W, Sun M.
    Oncotarget; 2017 Jun 13; 8(24):38227-38238. PubMed ID: 27246976
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
    Shi X, Ma C, Zhu Q, Yuan D, Sun M, Gu X, Wu G, Lv T, Song Y.
    Oncotarget; 2016 May 03; 7(18):25558-75. PubMed ID: 27027352
    [Abstract] [Full Text] [Related]

  • 14. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X, Liu Z, Liu Z, Feng X, Hua F, Hu X, Wang B, Lu K, Nie F.
    EBioMedicine; 2018 Nov 03; 37():177-187. PubMed ID: 30314898
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression.
    Cai Q, Jin L, Wang S, Zhou D, Wang J, Tang Z, Quan Z.
    Oncotarget; 2017 Jul 18; 8(29):47957-47968. PubMed ID: 28624787
    [Abstract] [Full Text] [Related]

  • 16. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC, Nie FQ, Jiang LL, Chen QN, Chen ZY, Chen X, Pan X, Liu ZL, Lu BB, Wang ZX.
    Oncotarget; 2017 Jan 17; 8(3):5233-5246. PubMed ID: 28029651
    [Abstract] [Full Text] [Related]

  • 17. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X, Zhang X, Yu B, Hu R, Hao L.
    Biochimie; 2017 Jun 17; 137():12-19. PubMed ID: 28223039
    [Abstract] [Full Text] [Related]

  • 18. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
    Liu Z, Chen Z, Fan R, Jiang B, Chen X, Chen Q, Nie F, Lu K, Sun M.
    Mol Cancer; 2017 Apr 26; 16(1):82. PubMed ID: 28441948
    [Abstract] [Full Text] [Related]

  • 19. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R, Zhang FH, Shen N.
    Biomed Pharmacother; 2017 Nov 26; 95():331-338. PubMed ID: 28858731
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 26; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.